Astera Labs, Inc. Common Stock (ALAB) Earnings
Astera Labs, Inc. Common Stock is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $0.69. ALAB has beaten EPS estimates in 1 of its last 1 reported quarters (average surprise +13.6% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 5, 2026 | $0.54 | $0.61 | +13.6% | $308M | +5.5% |
| Mar 21, 2024 | — | $0.09 | — | $51M | — |
| Sep 29, 2023 | — | $-0.02 | — | $37M | — |
| Mar 31, 2023 | — | $-0.13 | — | $18M | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 5, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Good afternoon, everyone, and welcome to Astera Labs' first quarter 2026 earnings conference call. Jitendra Mohan updated on AI infrastructure market trends, Q1 results, and recent announcements. Sanjay Gajendra outlined growth vision, including progress on standard products, optical business, custom solutions business, and platform business. Des Lynch reviewed Q1 financial results and Q2 guidance.
Guidance
Expect strong revenue growth to continue through 2026 and into 2027. Q2 revenue expected to be between $355 and $365 million, up 15% to 18% sequentially. Second quarter non-GAAP gross margin expected to be approximately 73%. Second quarter non-GAAP operating expenses expected to be between $128 and $131 million. Non-GAAP fully diluted earnings per share expected to be between 68 and 70 cents.
Segment performance
Revenue for the first quarter of 2026 was $308.4 million, up 14% versus the previous quarter and up 93% year over year. Revenue growth was broad-based across signal conditioning and switch fabric portfolios. PCIe Gen 6 revenue across AI fabric and signal conditioning contributed more than one third of total company revenue in the quarter. Scorpio product family performed well with initial production volumes of Scorpio X series products. Aries revenue grew on strong early adoption of PCIe 6 solutions. Taurus delivered solid results driven by broad adoption.
Risks & headwinds
Certain comments made may include forward-looking statements subject to risks and uncertainties. It is not possible to predict all risks and uncertainties that could impact forward-looking statements. Actual results could differ materially from those in forward-looking statements.
Analyst Q&A
Q: As customers' compute workloads inflect from training to inference, how has it created new opportunities?
A: Jitendra mentioned inferencing created opportunities like KVCache Offload and CorpUX 320-lane family with in-network compute and hypercast.
Q: On Scorpio ramp, how big is it and milestones for 320 lane product?
A: Des said Scorpio product family is a large driver, Scorpio X series newly introduced and will be demonstrated at Computex.
Q: About optical strategy, timeframe and building blocks?
A: Sanjay said NPO-based opportunities to ramp in 2027, pluggable connector technologies for CPO in 2027 with mainstream in 2028.
Q: On Leo product line, demand trajectory and growth potential?
A: Ross was told increased traction for CXL, on track for Microsoft Azure deployment and new KVCache offload design win.
Q: On Scorpio mix and Aries in 2027, how to think?
A: Des said Scorpio will be largest and fastest growing, Aries still has strong growth.
Q: On Scorpio X and P lanes post-26, lane count?
A: Jitendra said work closely with customers, focus on PCI Express and UAL products, lane count targeted based on customer deployment.
Q: On MVL infusion opportunity, custom solutions and competitive landscape?
A: Jitendra said deep in engagement for NVLink fusion devices, expect revenue in 2027, focus on real customers.
Q: On Scorpio business, ASPs for higher rated solutions?
A: Jitendra said bigger switch, higher ASP, combination of features and port count.
Q: On KB Cache Offload custom design, sizing opportunity?
A: Jitendra said it's significant opportunity, early to give exact numbers but inference and KVCache is big.
Q: On XPO and Sterilabs participation, view of customers?
A: Sanjay said work closely with customers, support NPO, CPO, and XPO as needed.
Q: On custom products and standard products, where's the line?
A: Jitendra said standard products offer customization via Cosmos, custom business has different model, both important.
Q: On UL Inc. adoption, update and dollar content?
A: Jitendra said hyperscaler customers' ASIC and GPU launch in 2027, UA-Link switch prepared, value higher than PCI Express.
Q: On capacity and inventory days, feeling on continuing revenue growth?
A: Des said comfortable with supply in place through end of year, work with supply chain for 2027.